This post was originally published on this site A diet low in carbohydrates may have cognitive benefits for older adults with mild cognitive impairment, a small study suggests. “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease” was published in the Journal of…

This post was originally published on this site Women who are carriers of the ApoE4 gene — a major genetic risk factor for the development of a late-onset form of Alzheimer’s disease, are more susceptible than men to accumulating toxic tau protein aggregates in the brain, a study suggests. This finding was shared in a…

This post was originally published on this site Alzheimer’s disease is a neurodegenerative condition that affects almost 6 million people in the United States. People with the disease experience mental decline, and symptoms include memory loss — but that’s not the only forfeiture. Alzheimer’s is the most common type of dementia. However, despite its prevalence,…

This post was originally published on this site Regardless of sex, people younger than age 65 who have a first-degree relative with Alzheimer’s disease generally showed poorer verbal and memory skills on a web-based test than their peers without this family history, a study’s results show. The study, “Family history of Alzheimer’s disease alters cognition…

This post was originally published on this site Long-term antibiotic treatment, aimed at altering the bacterial population in the gut, was found to reduce the inflammation and amyloid plaque formation that is a hallmark of Alzheimer’s disease — but only in male mice. The same treatment had no effect on female mice, a study found.…

This post was originally published on this site Genentech, a subsidiary of Roche, has launched a new substudy to learn more about the progression of early-onset familial Alzheimer’s disease, as part of its ongoing Alzheimer’s Prevention Initiative (API) trial evaluating crenezumab for preventing or delaying this genetic form of the disease. This substudy will examine the…

This post was originally published on this site The Alzheimer’s Association has chosen the summer solstice, June 21, to shed light on Alzheimer’s disease and to raise awareness about the mind-altering, life-changing condition through a fundraising event called The Longest Day. The second purpose is to raise funds for research to benefit the 53 million…

This post was originally published on this site A Phase 2a trial testing Oryzon’s investigational therapy vafidemstat for Alzheimer’s disease has enrolled its first patient in the U.S. The trial (NCT03867253), called ETHERAL-US, is an extension of the European trial (2017-004893-32), currently ongoing at 17 sites in the U.K., France, and Spain. Oryzon is planning…

This post was originally published on this site A vaccine produced using virus-like particles was able to improve cognitive functioning and reduce the accumulation of tau protein aggregates — a hallmark of Alzheimer’s disease — in a mouse model of the disease, a study shows. The study, “Qß Virus-like particle-based vaccine induces robust immunity and…

This post was originally published on this site A connection discovered between Alzheimer’s and the bacteria that cause gum disease suggests that improved oral hygiene may decrease the risk of developing the disorder, a study reports. The study, “Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors,” was published…

This post was originally published on this site In the United States, 2.1 million men age 65 and older have Alzheimer’s disease. With Father’s Day approaching, we recognize that these numbers represent many dads, though fewer men than women have the disease. Caregiving isn’t gender-specific. Among Americans age 71 and older, 16 percent of women…

This post was originally published on this site AxoSim has acquired exclusive rights to lab-grown brain miniatures, coined “Mini-Brain,” a technology developed at Johns Hopkins University that uses stem cells to create models of the human brain in a dish. The technique may help speed therapy discovery for many neurological diseases, including Alzheimer’s disease. “Acquiring rights to…